News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Leanne Edermaniger

Advertisement

Articles by Leanne Edermaniger

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    First patient dosed in phase I/II trial of complement-targeting gene therapy for geographic atrophy

    2

    OLN324 shows comparable vision gains, potential durability advantage vs faricimab in phase 1b wAMD, DME study

    3

    Merck launches phase 2b/3 MALBEC trial of MK-8748 in wet AMD

    4

    FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME

    5

    Getting to the root of geographic atrophy: Diagnosis and management

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us